Found: 11
Select item for more details and to access through your institution.
The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2451, doi. 10.1111/dom.14174
- By:
- Publication type:
- Article
Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1299, doi. 10.1111/dom.13649
- By:
- Publication type:
- Article
Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2022, n. 1, p. 1, doi. 10.1186/s12933-022-01601-w
- By:
- Publication type:
- Article
TRITON and Beyond: New Insights into the Profile of Prasugrel.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 4, p. e174, doi. 10.1111/j.1755-5922.2011.00263.x
- By:
- Publication type:
- Article
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
- Published in:
- American Journal of Health-System Pharmacy, 2003, v. 60, n. 12, p. 1251, doi. 10.1093/ajhp/60.12.1251
- By:
- Publication type:
- Article
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 2, p. 171, doi. 10.1177/1479164119827604
- By:
- Publication type:
- Article
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 6, p. 789, doi. 10.1177/0091270011406280
- By:
- Publication type:
- Article
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-17
- By:
- Publication type:
- Article
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE.
- Published in:
- 2020
- By:
- Publication type:
- letter